Investors eyeing a purchase of Vertex Pharmaceuticals, Inc. (NASD: VRTX) stock, but tentative about paying the going market price of $80.55/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $55 strike, which has a bid at the time of this writing of $7.30. Collecting that bid as the premium represents a 13.3% return against the $55 commitment, or a 8.3% annualized rate o...
Investors eyeing a purchase of Vertex Pharmaceuticals, Inc. (NASD: VRTX) stock, but tentative about paying the going market price of $80.55/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $55 strike, which has a bid at the time of this writing of $7.30. Collecting that bid as the premium represents a 13.3% return against the $55 commitment, or a 8.3% annualized rate o...
Share this Article
Recommended